Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Carcinoma and CHFR[original query] |
---|
Alternative efficacy-predicting markers for paclitaxel instead of CHFR in non-small-cell lung cancer. Cancer biology & therapy 2010 Nov 10 (9): 933-41. Takeshita Masafumi, Koga Takaomi, Takayama Koichi, Yano Tokujiro, Maehara Yoshihiko, Nakanishi Yoichi, Sueishi Kats |
CHFR hypermethylation and EGFR mutation are mutually exclusive and exhibit contrastive clinical backgrounds and outcomes in non-small cell lung cancer. International journal of cancer. Journal international du cancer 2011 Mar 128 (5): 1009-17. Koga Takaomi, Takeshita Masafumi, Yano Tokujiro, Maehara Yoshihiko, Sueishi Kats |
CHFR aberrant methylation involves a subset of human lung adenocarcinoma associated with poor clinical outcomes. Human pathology 2013 Jul 44 (7): 1382-90. Koga Takaomi, Takeshita Masafumi, Ijichi Kayo, Yano Tokujiro, Maehara Yoshihiko, Sueishi Kats |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: